Literature DB >> 12532444

Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex.

Xi Li1, Geng-Feng Fu, Yan-Rong Fan, Chan-Fu Shi, Xin-Juan Liu, Gen-Xing Xu, Jian-Jun Wang.   

Abstract

AIM: To obtain an efficient delivery system for transporting endostatin gene to mouse liver tumor xenografts by administration of aerosol.
METHODS: Recombinant plasmid pcDNA3.0/endostatin containing human endostatin gene together with signal peptide from alkaline phosphatase were transferred into human umbilical vein endothelial cell (HUVEC) by transferrin(TF)-liposome-endostatin complex. Western blot was used to detect the expression of human endostatin in transfected HUVEC cells and its medium. After the tumor-bearing mice were administrated with TF-liposome-endostatin complex, the lung tissue was analyzed by immunohistochemical method for expression of endostatin and the tumors were treated with CD-31 antibody to detect the density of microvessels in tumor tissues. The inhibition of tumor growth was estimated by the weight of tumors from groups treated with different doses of TF-liposome-endostatin complex. DNA fragmentation assay was used to detect the apoptosis of the cells from primary liver tumor.
RESULTS: Western blot analysis and immunohistochemical method confirmed the expression of endostatin protein in vitro and in vivo. After the tumor sections were treated with CD-31 antibody, the positive reaction cells appeared brown while the negative cells were colorless. The positively stained area of the TF-liposome-endostatin treated group was significantly smaller (P<0.01, 645.8+/-55.2 microm(2)) than that of the control group (1 325.4+/-198.5 microm(2)). The data showed a significant inhibition of angiogenesis. After administration of TF-liposome-endostatin, comparing with the control group administrated with TF-liposome-pcDNA3.0, liver tumor growth in the mice treated with 50, 250 and 500 mg DNA/kg was inhibited by 36.6 %, 40.8 %, and 72.8 %, respectively (P<0.01). And a typical DNA fragmentation of apoptosis was found in the cells from tumor tissues of the mice treated with TF-liposome-endostatin but none in the control group.
CONCLUSION: Endostatin gene could be efficiently transported into the mice with TF-liposome-DNA delivery system by administration of aerosol. TF-liposome-mediated endostatin gene therapy strongly inhibited angiogenesis and the growth of mouse xenograft liver tumors. It also could promote the development of apoptosis of tumors without direct influence on tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532444      PMCID: PMC4611324          DOI: 10.3748/wjg.v9.i2.262

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice.

Authors:  M J Stewart; G E Plautz; L Del Buono; Z Y Yang; L Xu; X Gao; L Huang; E G Nabel; G J Nabel
Journal:  Hum Gene Ther       Date:  1992-06       Impact factor: 5.695

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

4.  Endostatin induces endothelial cell apoptosis.

Authors:  M Dhanabal; R Ramchandran; M J Waterman; H Lu; B Knebelmann; M Segal; V P Sukhatme
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

5.  Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

Authors:  Y Yokoyama; M Dhanabal; A W Griffioen; V P Sukhatme; S Ramakrishnan
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

6.  Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy.

Authors:  Yang-Fu Jiang; Zhi-Hua Yang; Jin-Qun Hu
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

7.  Cloning, expression, and in vitro activity of human endostatin.

Authors:  M Dhanabal; R Volk; R Ramchandran; M Simons; V P Sukhatme
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

8.  Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts.

Authors:  L Xu; K F Pirollo; W H Tang; A Rait; E H Chang
Journal:  Hum Gene Ther       Date:  1999-12-10       Impact factor: 5.695

9.  Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.

Authors:  G Thurston; J W McLean; M Rizen; P Baluk; A Haskell; T J Murphy; D Hanahan; D M McDonald
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

10.  Angiostatin induces and sustains dormancy of human primary tumors in mice.

Authors:  M S O'Reilly; L Holmgren; C Chen; J Folkman
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

View more
  6 in total

1.  Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head.

Authors:  Jung Min Hong; Tae Ho Kim; Hyun Ju Kim; Eui Kyun Park; Eun Kyoung Yang; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

2.  Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo.

Authors:  Chun-Hong Ma; Yan Zhang; Xiao-Yan Wang; Li-Fen Gao; Hua Liu; Chun Guo; Su-Xia Liu; Ying-Lin Cao; Li-Ning Zhang; Wen-Sheng Sun
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.

Authors:  Pei-Yuan Li; Ju-Sheng Lin; Zuo-Hua Feng; Yu-Fei He; He-Jun Zhou; Xin Ma; Xiao-Kun Cai; De-An Tian
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

4.  Receptor binding characteristics and cytotoxicity of insulin-methotrexate.

Authors:  Xiao-Hong Ou; An-Ren Kuang; Zheng-Lu Liang; Xian Peng; Yu-Guo Zhong
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 5.  Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.

Authors:  Zhi Huang; Shi-Deng Bao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

6.  Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model.

Authors:  Sung-Yi Hong; Myun-Hee Lee; Kyung-Sup Kim; Hyun-Cheol Jung; Jae-Kyung Roh; Woo-Jin Hyung; Sung-Hoon Noh; Seung-Ho Choi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.